XML 35 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Leases
12 Months Ended
Dec. 31, 2024
Leases  
Leases

Note 8 — Leases

 

During the year ended December 31, 2024, the Company entered into additional lease agreements that have commenced and are classified as operating leases, including in June 2024, the Company exercised a renewal option to extend the lease term on its central laboratory in California for an additional three years, through December 31, 2027. The aggregate (undiscounted) rent payments are approximately $2.6 million over the extended lease term.

 

The components of lease expense were as follows:

 

         
   Year Ended December 31, 
   2024   2023 
Operating lease cost  $1,168   $1,214 
Short-term lease cost   74    87 
Variable lease cost   62    58 
Total lease cost  $1,304   $1,359 

 

 

Note 8 — Leases- continued

 

The Company’s future lease payments as of December 31, 2024, which are presented as operating lease liabilities, current portion and operating lease liabilities, less current portion on the Company’s consolidated balance sheets are as follows:

 

      
2025  $1,025 
2026   979 
2027   940 
2028   19 
2029    
Total lease payments  $2,963 
Less: imputed interest   (309)
Present value of lease liabilities  $2,654 

 

Supplemental disclosure of cash flow information related to the Company’s cash and non-cash activities with its leases are as follows:

 

         
   Years Ended December 31, 
   2024   2023 
Cash paid for amounts included in the measurement of lease liabilities          
Operating cash flows from operating leases  $1,148   $1,207 
Non-cash investing and financing activities          
Right-of-use assets obtained in exchange for new operating lease liabilities  $2,347   $380 
Weighted-average remaining lease term - operating leases (in years)   2.95    1.39 
Weighted-average discount rate - operating leases   7.875%   7.875%

 

As of December 31, 2024 and December 31, 2023, the Company’s right-of-use assets from operating leases were $2,637 and $1,307, respectively, which are reported in operating lease right-of-use assets in the consolidated balance sheets. As of December 31, 2024 and December 31, 2023, the Company had outstanding operating lease obligations of $2,654 and $1,305, respectively, of which $854 and $1,106, respectively, are reported in operating lease liabilities, current portion and $1,800 and $199, respectively, are reported in operating lease liabilities less current portion in the Company’s consolidated balance sheets. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the financing terms the Company would likely receive on the open market.